feedback

Activity Details

Free CNE
0.75 Contact Hour(s)
Released: October 8, 2020
Expires: October 7, 2021
45 minutes to complete

Accredited By

This continuing nurse education activity is provided by

Target Audience

The intended audience for this activity is registered nurses (RNs), nurse practitioners (NPs), oncology RNs, oncology NPs, hemophilia RNs, hemophilia NPs, hemophilia treatment center RNs, hemophilia treatment center NPs, and other health care professionals involved in the management of patients with hemophilia A.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess the latest evidence regarding treatments for patients with hemophilia A that may reduce treatment burden and enhance quality of life.
  • Identify patients with hemophilia A without factor VIII inhibitors who may benefit from newer treatment options.
  • Review strategies for educating patients with hemophilia A about their disease state and treatment options to facilitate the use of shared decision-making and improve patient satisfaction.

Activity Description

Hemophilia A is an X-linked recessive disease primarily affecting men, with an estimated 20,000 individuals in the United States having the disease. Disease severity is related to the degree to which factor VIII (FVIII) levels are reduced, with patients often requiring multiple infusions a week. Newer approaches to treating hemophilia A include extended half-life FVIII products that allow for reduced dosing, as well as emicizumab, a bispecific antibody therapy that mimics the cofactor activity of factor VIII by binding to and bridging activated factor IX and factor X. Given recent developments that include new drug approvals, expanded drug indications, and self-administration options, education is needed to keep clinicians apprised of best practices for managing hemophilia A in patients with and without inhibitors. In this CNE activity, expert faculty examine the latest evidence regarding new and emerging treatments for patients with hemophilia A and provide guidance on identifying patients with and without factor VIII inhibitors who may benefit from newer treatment options. Additionally, faculty will discuss strategies to promote shared decision-making and improve patient satisfaction.

Agenda

Introduction and Background
Regina B. Butler, RN-BC

Advances in the Management of Patients With Hemophilia A – Differentiating Options
Kerry Hansen, RN-BC

Optimizing Communication, Patient Education, and Shared Decision-Making in Patients With Hemophilia A
James E. Munn, MS, BS, BSN, RN-BC

Faculty

Activity Chair:

Regina B. Butler, RN-BC
Director, Mid-Atlantic/Region III Hemophilia Treatment Centers
Clinical Manager, Division of Hematology
Children's Hospital of Philadelphia
Philadelphia, PA

Disclosure:
Consulting Fee: Genentech, Pfizer


Faculty:

Kerry Hansen, RN, BSN
Nurse Clinician
M Health Fairview
University of Minnesota
Minneapolis, MN

Disclosure: No relevant financial relationships to disclose.


James E. Munn, MS, BS, BSN, RN-BC
Program Nurse Coordinator
University of Michigan Medical Center
Ann Arbor, MI

Disclosure:
Consulting Fee: Bayer, Sanofi Genzyme
Advisory Board: CSL Behring, Genentech, Novo Nordisk, Octapharma, Takeda


Reviewers:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to disclose.

Barbara A. Niedz, PhD, RN, CPHQ
Disclosure:
Consulting Fee: Beckton Dickinson
Contracted Research: Beckton Dickinson

Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to disclose. 

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Conflict of Interest Policy/Disclosure Statement

In accordance with the American Nurses Credentialing Center’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.

Accreditation Statement

Vindico Medical Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation of Credit

Vindico Medical Education will provide a maximum of 0.75 contact hour for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved for 0.75 contact hour(s) of continuing education by the American Association of Nurse Practitioners. Activity ID 20094522. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Instructions for Receiving Credit

To participate in this CNE activity, you must read the objectives, answer the pretest questions, view the CNE content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue a Contact Hours Certificate.

Statement of Commercial Support

This activity is supported by an educational grant from Genentech, Inc.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

Disclaimer Statement/Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CNE Questions?

Contact us at CME@VindicoCME.com

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.